PATENT CLAIM ANALYSIS

Application Number: 15937388
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "274100"]

Abstract:
This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the invention exhibit one or more advantages over conventional botulinum toxin formulations, including reduced antigenicity, a reduced tendency to undergo unwanted localized diffusion following injection, increased duration of clinical efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or improved stability.

Claim (Index 8):
The kit according to  claim 3 , wherein the therapeutic or cosmetic effect results from local muscle paralysis following injection of said botulinum toxin component, said positively charged carrier, and said pharmaceutically acceptable diluent, and wherein said local muscle paralysis lasts longer than local muscle paralysis following injection of the same dose of botulinum toxin units from a formulation of 100 U of type A botulinum toxin with accessory protein, 0.5 mg of human albumin, and 0.9 mg of sodium chloride.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.32203
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13141935', '14935886', '11367642', '11072026', '11816602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7378360693967343
- 35 USC 102 Novelty (BERT): 0.5737623655805162
- Combined Prediction Score: 0.7214286990151124
- Mean Citation Score: 360.877898
- Max Citation Score: 453.47833
- Similarity Product: 391.39292653128336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test